Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.

Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W; Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators..

N Engl J Med. 2002 Oct 10;347(15):1143-50.

2.

Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin.

Fasullo S, Scalzo S, Maringhini G, Ganci F, Cannizzaro S, Basile I, Cangemi D, Terrazzino G, Parrinello G, Sarullo FM, Baglini R, Paterna S, Di Pasquale P.

Am J Med Sci. 2011 Jan;341(1):33-9. doi: 10.1097/MAJ.0b013e3181f1fc3e.

PMID:
20890176
3.

Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism.

Perlroth DJ, Sanders GD, Gould MK.

Arch Intern Med. 2007 Jan 8;167(1):74-80.

PMID:
17210881
4.

Should thrombolytic therapy be used in patients with pulmonary embolism?

Konstantinides S.

Am J Cardiovasc Drugs. 2004;4(2):69-74. Review.

PMID:
15049719
5.

Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism.

Becattini C, Agnelli G, Salvi A, Grifoni S, Pancaldi LG, Enea I, Balsemin F, Campanini M, Ghirarduzzi A, Casazza F; TIPES Study Group..

Thromb Res. 2010 Mar;125(3):e82-6. doi: 10.1016/j.thromres.2009.09.017.

PMID:
19833379
7.

Thrombolytic-plus-Anticoagulant Therapy versus Anticoagulant-Alone Therapy in Submassive Pulmonary Thromboembolism (TVASPE Study): A Randomized Clinical Trial.

Taherkhani M, Taherkhani A, Hashemi SR, Faghihi Langroodi T, Sadeghi R, Beyranvand M.

J Tehran Heart Cent. 2014;9(3):104-8.

8.

Effectiveness and cost effectiveness of thrombolysis in patients with acute pulmonary embolism.

Zamanian RT, Gould MK.

Curr Opin Pulm Med. 2008 Sep;14(5):422-6. doi: 10.1097/MCP.0b013e328307ee0f. Review.

PMID:
18664972
9.

Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galiè N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV; PEITHO Investigators..

N Engl J Med. 2014 Apr 10;370(15):1402-11. doi: 10.1056/NEJMoa1302097.

10.

Thrombolysis for pulmonary embolism.

Goldhaber SZ.

N Engl J Med. 2002 Oct 10;347(15):1131-2. No abstract available.

PMID:
12374871
11.

Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial.

Kline JA, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT, Diercks DB, Klinger JR, Hernandez J.

J Thromb Haemost. 2014 Apr;12(4):459-68. doi: 10.1111/jth.12521.

12.

Comparison of alteplase versus heparin for resolution of major pulmonary embolism.

Konstantinides S, Tiede N, Geibel A, Olschewski M, Just H, Kasper W.

Am J Cardiol. 1998 Oct 15;82(8):966-70.

PMID:
9794353
13.

PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2.

Dalla-Volta S, Palla A, Santolicandro A, Giuntini C, Pengo V, Visioli O, Zonzin P, Zanuttini D, Barbaresi F, Agnelli G, et al.

J Am Coll Cardiol. 1992 Sep;20(3):520-6.

PMID:
1512328
14.

[The efficacy of alteplase in pulmonary embolism treatment].

Malinovskiń≠ NN, Gruzdev AK, Beskaeva LM, Sal' nikov DV, Nikerov KIu, Abramov AS, Fineshin IN.

Khirurgiia (Mosk). 2008;(7):4-7. Russian.

PMID:
18833155
15.

Thrombolytic therapy for pulmonary embolism.

Hao Q, Dong BR, Yue J, Wu T, Liu GJ.

Cochrane Database Syst Rev. 2015 Sep 30;(9):CD004437. doi: 10.1002/14651858.CD004437.pub4. Review.

PMID:
26419832
16.

Thrombolytic therapy for submassive pulmonary embolism.

Lankeit M, Konstantinides S.

Best Pract Res Clin Haematol. 2012 Sep;25(3):379-89. doi: 10.1016/j.beha.2012.06.005. Review.

PMID:
22959553
17.

Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.

Tebbe U, Graf A, Kamke W, Zahn R, Forycki F, Kratzsch G, Berg G.

Am Heart J. 1999 Jul;138(1 Pt 1):39-44.

PMID:
10385761
18.

Thrombolytic therapy in patients with submassive pulmonary embolism.

Ajani AE, Waksman R.

N Engl J Med. 2003 Jan 23;348(4):357-9; author reply 357-9. No abstract available.

PMID:
12542063
20.

Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis.

Nakamura S, Takano H, Kubota Y, Asai K, Shimizu W.

J Thromb Haemost. 2014 Jul;12(7):1086-95. doi: 10.1111/jth.12608.

Supplemental Content

Support Center